Urometer Market
Report ID: SQMIG35A3688
Report ID: SQMIG35A3688
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3688 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
118
|Figures:
77
Global Urometer Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 193.67 Million in 2025 to USD 312.4 Million by 2033, growing at a CAGR of 6.12% during the forecast period (2026-2033).
As a market, urometer devices encompass instruments that measure and record urinary output for clinical and home use, and their importance stems from the direct link between urine measurements and patient fluid balance, renal function and critical care decisions. Historically the sector moved from passive graduated collection bags and manual charting toward calibrated mechanical meters and electronic flow sensors that enable time-stamped recording and alarm functions, driven by hospital quality imperatives and the need to reduce measurement error. For example, intensive care units and post-operative wards adopted automated meters to improve responsiveness to oliguria and standardize documentation across care teams.
Building on growing clinical demand, technological innovation serves as the key trend driving the global urometer sector expansion because digital sensors, connectivity and analytics reduce measurement error, enable continuous monitoring and integrate data into electronic health records, which in turn persuades hospitals to invest in automated systems to improve outcomes and operational efficiency. As a consequence, manufacturers pursue miniaturized, wireless urometers and subscription-based data services that lower total cost of ownership and enable remote patient monitoring for chronic kidney disease management, post-surgical follow-up and eldercare in nursing homes, creating clear commercial pathways into emerging markets where hospital infrastructure upgrades are underway.
How is Iot Enhancing Real-time Monitoring in the Urometer Market?
Real time monitoring in the urometer market relies on connected sensors that track urine volume and related markers and stream those readings to hospital dashboards and remote portals. Core features consist of ongoing Detection, wireless communication, and automated notification of decreased production or abrupt fluctuations in production. The current trend is a transition from routine manual monitoring to devices that capture patterns of behavior using sensors and alleviate the burden of employee functions. In addition, in terms of market evolution, both Clinical and Home are being developed in response to increasing utilization of Sensor-Enabled Urodynamics and Toilet-Based Analyzers. This adds to the number of locations and types of services being provided to a wider range of patients, rather than only to critically ill patients in an Inpatient Care Environment.
In May 2026, Bright Uro received FDA clearance for its Glean abdominal sensor, illustrating a real world advance. This IoT enabled device supports market growth by delivering continuous non invasive bladder monitoring and remote alerts that improve clinical efficiency and decision making.
Market snapshot - (2026-2033)
Global Market Size
USD 182.5 Million
Largest Segment
Standard Urometers
Fastest Growth
Automated Electronic Urometers
Growth Rate
6.12% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global urometer market is segmented by product type, capacity, end-user, distribution and region. Based on product type, the market is segmented into standard urometers, automated electronic urometers and disposable urometers. Based on capacity, the market is segmented into below 500 mL, 500-1000 mL and above 1000 mL. Based on end-user, the market is segmented into hospitals (ICU, OR), clinics and home care. Based on distribution, the market is segmented into direct to hospitals, medical distributors and online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on the global urometer market growth, automated electronic urometers segment dominates because their real time measurement and connectivity directly address acute care monitoring priorities, prompting clinicians and procurement teams to prefer integrated solutions that enhance patient safety. The combination of improved measurement accuracy, alarm functions, and interoperability with electronic health records reduces manual workload and supports timely decision making, which in turn drives institutional purchasing and entrenches these devices in critical care workflows.
However, disposable urometers are emerging as the most rapidly expanding area because infection control advantages and minimal maintenance encourage adoption in single use focused care settings. Their straightforward design and simplified logistics allow fast deployment across outpatient and community care sites, creating new demand corridors and enabling manufacturers to capture growth by offering lower complexity, high turnover products suited to diverse care environments.
Hospitals (ICU, OR) segment dominates because high acuity units require continuous, accurate urine measurement and resilient monitoring solutions that meet stringent clinical standards, making hospitals primary purchasers of advanced urometers. Supplier's motivation to develop and deliver products with hospital-grade features is based on an ongoing need for reliable data to inform clinicians on fluid management, the need to integrate data with continuous monitoring systems, and the need for user-friendly interfaces.
Meanwhile, home care is witnessing the strongest growth momentum due to rising demand for portable, easy to use urometers compatible with remote monitoring and self care. Emphasis on user friendly design and low maintenance expands applicability outside traditional clinical settings, unlocking new revenue streams and accelerating opportunities for manufacturers adapting devices to consumer oriented care models.
To get detailed segments analysis, Request a Free Sample Report
As per the global urometer market share, North America dominates the industry through mature healthcare infrastructure, concentrated investment in urology research, and a regulatory and reimbursement environment that supports adoption of advanced monitoring tools. The widespread presence of hospitals, clinics and home health care organizations allows for ongoing deployment and support of the technology in combination with established manufacturers provide the strength of commercial and technical support throughout the region. Communication among clinicians, payers and the industry creates a collaborative environment for clinical validation and the establishment of new devices in market. The strength of the quality standards, training programs, telehealth and electronic medical record integration provide the technical foundation to create comfort for clinicians in the use of remote patient care. The presence of competitive suppliers and active private investors in the supply chain, assure the continued development of products and the continued availability of reliable support services in the form of aftermarket support services.
Urometer market in United States benefits from a dense clinical network, high clinician familiarity with urology diagnostics, and a strong ecosystem of manufacturers and distributors. Reliable monitoring solutions are an important priority for hospitals and home health care agencies. This requires developing education and support services to minimize the barriers to adopting these types of products. Product development and clinical validation occur through collaborative research centers or through private funds. The integration of the products with health information systems and telehealth is also helpful to both care teams and patients.
Urometer market in Canada reflects strengths in integrated public healthcare delivery and engagement of community care in urology monitoring. Standardized adoption of devices and training is facilitated through provincial procurement frameworks and clinical networks. In addition, local distributors and service partners provide responsive maintenance and education. Research collaborations with academic hospitals and patient experience also contribute to developing solutions that have good clinical reliability and are easy to use which supports increased use across institutions and home care.
Based on global urometer regional forecaat, Europe is experiencing rapid expansion in the industry driven by increasing emphasis on outpatient and home-based urology care, harmonized regulatory pathways, and stronger collaboration between industry and clinical networks. Health systems in this region are focusing on remote monitoring and integrated clinical pathways. They are aiming to lessen the burden on hospitals, and improve the continuity of care; hence there is a demand for urometer solutions that are both accessible and can easily communicate with other urometer devices or services. The increasing local manufacturing and distribution capabilities shorten supply chains and provide more responsive service, while regional standards and clinical guidelines provide clear guidance for manufacturer’s respective urometer device and service implementations. Investments into the infrastructure for digital health, along with the establishment of cross-border clinical studies, increases the acceptance of urometer devices in clinical practice.
Urometer market in Germany draws strength from a robust hospital network, clinical research in urology and an established medical device manufacturing base. Procurement processes and clinical guideline frameworks support rigorous evaluation and adoption of reliable monitoring technologies. The collaboration between educational institutions and businesses helps to facilitate clinical trials and develop products, and the distributors of these products will provide installation and maintenance.
Urometer market in United Kingdom is shaped by a public health system emphasizing efficient care, growing interest in remote monitoring, and active private sector innovation. Evaluation of urometer technology by hospital and community use is supported by the procurement pilots and regional innovation hubs. A focus on interoperability with electronic records and telecare platforms will support its adoption. Additionally, partnerships between startup companies and established suppliers will expedite commercialization.
Urometer market in France is gaining momentum driven by reforms that expand community care and by growing interest in home-based monitoring solutions. Focusing on patient experience and caregiver training prior to full implementation improves acceptance of clinical devices in locations outside of hospitals. Integration of clinical devices with health information systems provides improved remote monitoring capabilities. Collaboration among hospitals, manufacturers, and payers will help to ensure that the clinical device market is actively developing.
As per global urometer regional outlook, Asia Pacific is strengthening its position in the industry through a blend of targeted healthcare investment, rapid adoption of digital health technologies, and growing local manufacturing capabilities that lower costs and improve supply resilience. As part of wider efforts to improve outpatient and community care, remote monitoring is gaining acceptance by government and private payers, which opens up opportunities for customized interoperable solutions. Partnerships between local companies and international suppliers facilitate technology transfer and validation; while clinical centers in the region generate evidence. User-friendly designs, multi-lingual interfaces, compact devices address the diversity of care settings, and expanded service and distribution networks improve aftersales support and increase market access across the region. Regulatory reform and pilot reimbursement programs in several markets have removed barriers to commercialization; while focused clinician training and national digital health strategies will support the scaling of remote monitoring as routine practice.
Urometer market in Japan benefits from advanced healthcare infrastructure, high clinician engagement in urology and strong domestic electronics manufacturing expertise. Hospitals and clinics focus on having integrated monitoring systems that match their electronic records. Collaboration between manufacturers and academic centers adds value to clinical evaluation and provides support for innovation through incremental product modifications. With increasing interest in home-based care and telehealth services, manufacturers will develop compact, user-friendly devices and have strong aftersales support networks for these devices.
Urometer market in South Korea is characterized by strong technology adoption, advanced medical electronics capabilities, and collaboration with hospitals and manufacturers. The national digital healthcare efforts and pilot programs for payment offer positive opportunities for the long-term care sectors, while nimble, innovative startups are working together with established product vendors to develop better usability and connectivity of devices available for patients. Clinical facilities have the capability to produce and validate their own quality of evidence to support remote monitoring solutions.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Aging Population Driving Demand
Technological Innovation Enhancing Device Capabilities
High Acquisition and Maintenance Costs
Regulatory Approval and Reimbursement Barriers
Request Free Customization of this report to help us to meet your business objectives.
Competition in the global urometer market outlook is intensifying as device makers pursue M&A, strategic partnerships and sensor innovation to secure hospital procurement and ICU adoption; for example Observe Medical acquired the Unometer portfolio from ConvaTec and Bright Uro has raised funding to advance a wireless urodynamics meter. Commercialization speed and EHR integration remain key competitive drivers.
Top Player’s Company Profile
Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global urometer industry is gaining traction driven primarily by technological innovation that improves accuracy, connectivity and integration with electronic health records, while an aging population further amplifies demand for continuous urinary monitoring. Automated electronic urometers lead the market, favored in acute care for real time measurement and interoperability, and North America remains the dominant region because of mature healthcare infrastructure and strong adoption of advanced monitoring. High costs for purchasing and maintaining equipment have limited the ability of hospitals to acquire and deploy new products. Manufacturers developing user-friendly, connected devices and subscription data services will have a stronger opportunity for growth than competitors, in both clinical hospital and home-care market segments.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 182.5 Million |
| Market size value in 2033 | USD 312.4 Million |
| Growth Rate | 6.12% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Urometer Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Urometer Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Urometer Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Urometer Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Urometer Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 193.67 Million in 2025 to USD 312.4 Million by 2033, growing at a CAGR of 6.12% during the forecast period (2026-2033).
Competition in the global urometer market is intensifying as device makers pursue M&A, strategic partnerships and sensor innovation to secure hospital procurement and ICU adoption; for example Observe Medical acquired the Unometer portfolio from ConvaTec and Bright Uro has raised funding to advance a wireless urodynamics meter. Commercialization speed and EHR integration remain key competitive drivers. 'Bard Medical (Becton Dickinson)', 'Coloplast A/S', 'Smiths Medical (ICU Medical)', 'Teleflex Inc.', 'Rochester Medical (C.R. Bard)', 'Medline Industries', 'ConvaTec Group', 'Hollister Inc.', 'Cardinal Health', 'McKesson Corporation', 'Welch Allyn (Hill-Rom)', 'GreenField Medical', 'Urocare Products', 'Marlen Manufacturing', 'Transurological Care', 'Rusch (Teleflex)', 'Critchley Electrical Products', 'Macromed', 'Vyaire Medical', 'Dale Medical Products'
The growing prevalence of urinary disorders among aging populations increases clinical emphasis on accurate fluid management and continuous monitoring, which drives demand for urometers in hospitals and long term care settings. Clinicians view precise urine measurement as integral to patient assessment and treatment planning, prompting procurement and integration into care pathways. Improved patient outcomes associated with diligent monitoring encourage adoption of urometer devices across care settings. This sustained clinical focus on monitoring needs supports market expansion by creating steady institutional demand and procurement priorities.
Digital Integration And Connectivity: Manufacturers and service providers are prioritizing seamless interoperability between urometers and electronic health systems to support remote monitoring and care coordination. Emphasis on secure data exchange, standardized communication protocols, and integration with telehealth platforms enhances clinical workflows and enables longitudinal tracking of urinary metrics across care settings. This trend is driving partnerships between device makers and software firms, fostering modular solutions that simplify deployment in hospitals and ambulatory settings while improving clinician access to patient-generated data for informed decision making.
Why does North America Dominate the Global Urometer Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
